• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UDP-葡萄糖醛酸基转移酶(UGT)典型配体对β-葡萄糖醛酸酶(GUS)的抑制作用。

Inhibitory effects of UDP-glucuronosyltransferase (UGT) typical ligands against beta-glucuronidase (GUS).

作者信息

Xiao Ling, Chi Dehui, Sheng Guiju, Li Wenjuan, Lin Penghui, Liang Sicheng, Zhu Liangliang, Dong Peipei

机构信息

School of Resources and Environment, Key Laboratory of Aqueous Environment Protection and Pollution Control of Yangtze River, Anqing Normal University Anqing 246133 China.

Department of Food Science and Technology, School of Life Science and Research Center of Aquatic Organism Conservation and Water Ecosystem Restoration, Anqing Normal University No. 1314, North Jixian Road Anqing 246133 China

出版信息

RSC Adv. 2020 Jun 16;10(39):22966-22971. doi: 10.1039/d0ra02311f.

DOI:10.1039/d0ra02311f
PMID:35520305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9054634/
Abstract

UDP-glucuronosyltransferases (UGTs) and β-glucuronidase (GUS) catalyze entirely distinct metabolism reactions. UGTs are responsible for the glucuronidation of a variety of drugs, endogenous and environmental chemicals, whereas GUS hydrolyzes glucuronides and liberates the parent substrates. Information on the overlap of ligand selectivity between UGT and GUS is essential for exploring the pharmacological or toxicological effects of the inhibitors of these two metabolic enzymes. This study is conducted to test whether UGTs and GUS share common ligands, by investigating the inhibitory effects towards GUS by a series of UGT typical substrates and inhibitors. Results showed that three typical ligands of UGTs, including two specific substrates (estradiol and trifluoperazine, E2 and TFP) and one selective inhibitor (magnolol, Mag), can inhibit the activity of GUS. Kinetic assays indicated that all the three UGT specific chemicals displayed competitive inhibition, with values of 31.4 (E2), 56.9 (TFP), and 16.6 μM (Mag). Docking studies further revealed that the three chemicals can enter the active sites of GUS by forming contacts with residues Glu-413, Trp-549, Asp-163, Tyr-472, Arg-562, or bound water. Our study indicates that ligand selectivity overlaps between UGTs and GUS, and some chemicals can act as co-inhibitors of these two metabolic enzymes. The pharmacological or toxicological effects of those co-inhibitors require further investigations.

摘要

尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)和β-葡萄糖醛酸酶(GUS)催化完全不同的代谢反应。UGTs负责多种药物、内源性和环境化学物质的葡萄糖醛酸化,而GUS则水解葡萄糖醛酸酯并释放出母体底物。了解UGT和GUS之间配体选择性的重叠情况对于探索这两种代谢酶抑制剂的药理或毒理作用至关重要。本研究旨在通过研究一系列UGT典型底物和抑制剂对GUS的抑制作用,来测试UGTs和GUS是否共享共同配体。结果表明,UGTs的三种典型配体,包括两种特异性底物(雌二醇和三氟拉嗪,E2和TFP)和一种选择性抑制剂(厚朴酚,Mag),可以抑制GUS的活性。动力学分析表明,所有这三种UGT特异性化学物质均表现出竞争性抑制作用,其 值分别为31.4(E2)、56.9(TFP)和16.6 μM(Mag)。对接研究进一步揭示,这三种化学物质可通过与残基Glu-413、Trp-549、Asp-163、Tyr-472、Arg-562或结合水形成接触而进入GUS的活性位点。我们的研究表明,UGTs和GUS之间存在配体选择性重叠,一些化学物质可作为这两种代谢酶的共同抑制剂。这些共同抑制剂的药理或毒理作用需要进一步研究。

相似文献

1
Inhibitory effects of UDP-glucuronosyltransferase (UGT) typical ligands against beta-glucuronidase (GUS).UDP-葡萄糖醛酸基转移酶(UGT)典型配体对β-葡萄糖醛酸酶(GUS)的抑制作用。
RSC Adv. 2020 Jun 16;10(39):22966-22971. doi: 10.1039/d0ra02311f.
2
Diverse effects of α-/β-estradiol on catalytic activities of human UDP-glucuronosyltransferases (UGT).α-/β-雌二醇对人尿苷二磷酸葡萄糖醛酸基转移酶(UGT)催化活性的多种影响。
J Steroid Biochem Mol Biol. 2023 Jan;225:106196. doi: 10.1016/j.jsbmb.2022.106196. Epub 2022 Sep 28.
3
Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.鬼臼毒素(PT)类似物对尿苷二磷酸葡萄糖醛酸转移酶(UGT)同工型的构效关系。
Pharmazie. 2015 Apr;70(4):239-43.
4
Regulation profile of phosphatidylcholines (PCs) and lysophosphatidylcholines (LPCs) components towards UDP-glucuronosyltransferases (UGTs) isoforms.磷脂酰胆碱(PCs)和溶血磷脂酰胆碱(LPCs)成分对尿苷二磷酸葡萄糖醛酸转移酶(UGTs)同工型的调控概况。
Xenobiotica. 2015 Mar;45(3):197-206. doi: 10.3109/00498254.2014.966174. Epub 2014 Sep 26.
5
A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors.一种人源 UDP-葡糖醛酸基转移酶的广谱底物及其在葡糖醛酸转移酶抑制剂研究中的应用。
Int J Biol Macromol. 2021 Jun 1;180:252-261. doi: 10.1016/j.ijbiomac.2021.03.073. Epub 2021 Mar 16.
6
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.UDP对UDP-葡萄糖醛酸基转移酶(UGT)的产物抑制作用掩盖了UGT底物的抑制效果。
Drug Metab Dispos. 2008 Feb;36(2):361-7. doi: 10.1124/dmd.107.018705. Epub 2007 Nov 12.
7
Potent inhibition of tributyltin (TBT) and triphenyltin (TPT) against multiple UDP-glucuronosyltransferases (UGT): A new potential mechanism underlying endocrine disrupting actions.强效抑制三丁基锡(TBT)和三苯基锡(TPT)对多种尿苷二磷酸葡萄糖醛酸转移酶(UGT)的作用:内分泌干扰作用的新潜在机制。
Food Chem Toxicol. 2021 Mar;149:112039. doi: 10.1016/j.fct.2021.112039. Epub 2021 Feb 4.
8
The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A.维生素A对尿苷二磷酸葡萄糖醛酸转移酶(UGTs)的抑制作用。
Xenobiotica. 2017 May;47(5):376-381. doi: 10.1080/00498254.2016.1198841. Epub 2016 Jun 30.
9
Selectivity for inhibition of nilotinib on the catalytic activity of human UDP-glucuronosyltransferases.尼洛替尼对人尿苷二磷酸葡萄糖醛酸转移酶催化活性抑制的选择性。
Xenobiotica. 2014 Apr;44(4):320-5. doi: 10.3109/00498254.2013.840750. Epub 2013 Sep 25.
10
Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.人尿苷二磷酸葡萄糖醛酸转移酶的底物(三氟拉嗪)和抑制剂(阿米替林、雄甾酮、坎利酮酸、海柯皂苷元、保泰松、奎尼丁、奎宁和磺吡酮)“探针”的选择性。
Drug Metab Dispos. 2006 Mar;34(3):449-56. doi: 10.1124/dmd.105.007369. Epub 2005 Dec 28.

引用本文的文献

1
In Vitro Inhibitory Effects and Molecular Mechanism of Four Theaflavins on Isozymes of CYP450 and UGTs.四种茶黄素对CYP450同工酶和UGTs的体外抑制作用及分子机制
Foods. 2025 Aug 14;14(16):2822. doi: 10.3390/foods14162822.
2
In Vitro Ciclopirox Glucuronidation in Liver Microsomes from Humans and Various Experimental Animals.人及各种实验动物肝微粒体中环吡酮葡胺的体外葡萄糖醛酸化。
Eur J Drug Metab Pharmacokinet. 2024 Sep;49(5):619-629. doi: 10.1007/s13318-024-00907-2. Epub 2024 Jul 11.
3
The tremendous clinical potential of the microbiota in the treatment of breast cancer: the next frontier.

本文引用的文献

1
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.β-葡萄糖醛酸酶活性及其抑制剂的治疗意义:综述。
Eur J Med Chem. 2020 Feb 1;187:111921. doi: 10.1016/j.ejmech.2019.111921. Epub 2019 Dec 4.
2
Potential of herb-drug / herb interactions between substrates and inhibitors of UGTs derived from herbal medicines.草药药物/草药相互作用的潜力,来源于草药的 UGTs 的底物和抑制剂。
Pharmacol Res. 2019 Dec;150:104510. doi: 10.1016/j.phrs.2019.104510. Epub 2019 Oct 31.
3
A dual system platform for drug metabolism: Nalbuphine as a model compound.
肠道菌群在乳腺癌治疗中的巨大临床潜力:下一个前沿。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12513-12534. doi: 10.1007/s00432-023-05014-4. Epub 2023 Jun 29.
4
The Role of Gut Microbial β-Glucuronidase in Estrogen Reactivation and Breast Cancer.肠道微生物β-葡萄糖醛酸酶在雌激素再激活及乳腺癌中的作用
Front Cell Dev Biol. 2021 Aug 12;9:631552. doi: 10.3389/fcell.2021.631552. eCollection 2021.
双系统药物代谢平台:纳布啡作为模型化合物。
Eur J Pharm Sci. 2020 Jan 1;141:105093. doi: 10.1016/j.ejps.2019.105093. Epub 2019 Oct 21.
4
Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.帕唑帕尼通过抑制 UGT1A1 介导的 SN-38 葡萄糖醛酸化,而非 OATP1B1 介导的肝摄取,与伊立替康相互作用,SN-38 是一种活性代谢物。
Cancer Chemother Pharmacol. 2019 May;83(5):993-998. doi: 10.1007/s00280-019-03784-8. Epub 2019 Feb 13.
5
Chemical Probes for Human UDP-Glucuronosyltransferases: A Comprehensive Review.用于人类尿苷二磷酸葡萄糖醛酸转移酶的化学探针:全面综述。
Biotechnol J. 2019 Jan;14(1):e1800002. doi: 10.1002/biot.201800002. Epub 2018 Sep 27.
6
Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.定量描述人肝和肠中的 UDP-葡糖醛酸基转移酶 2B17 及其在睾酮首过代谢中的作用。
Biochem Pharmacol. 2018 Oct;156:32-42. doi: 10.1016/j.bcp.2018.08.003. Epub 2018 Aug 4.
7
UDP-glucuronosyltransferases: Structure, Function and Drug Design Studies.UDP-葡糖醛酸基转移酶:结构、功能和药物设计研究。
Curr Med Chem. 2018;25(27):3247-3255. doi: 10.2174/0929867325666180226111311.
8
Inhibition of Human UGT1A1-Mediated Bilirubin Glucuronidation by Polyphenolic Acids Impact Safety of Popular Salvianolic Acid A/B-Containing Drugs and Herbal Products.多酚酸抑制人 UGT1A1 介导的胆红素葡萄糖醛酸化对含丹参酸 A/B 的常用药物和草药产品安全性的影响。
Mol Pharm. 2017 Sep 5;14(9):2952-2966. doi: 10.1021/acs.molpharmaceut.7b00365. Epub 2017 Jun 22.
9
Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase.黄酮类化合物作为大肠杆菌β-葡萄糖醛酸酶天然抑制剂的构效关系
Food Chem Toxicol. 2017 Nov;109(Pt 2):975-983. doi: 10.1016/j.fct.2017.03.042. Epub 2017 Mar 24.
10
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.环丙沙星阻断了双氯芬酸的肠肝循环,并部分通过抑制肠道β-葡萄糖醛酸酶活性减轻了大鼠非甾体抗炎药诱导的肠病。
Acta Pharmacol Sin. 2016 Jul;37(7):1002-12. doi: 10.1038/aps.2016.54. Epub 2016 May 16.